Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02776215
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:53.030591+00:00
Published At
2024-03-21T00:00:00+00:00
Record Updated At
2024-03-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Circadian Rhythm Sleep Disorders", "Non-24 Hour Sleep-Wake Disorder", "Autism Spectrum Disorder", "Smith-Magenis Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-21"
protocolSection.identificationModule.nctId
"NCT02776215"
protocolSection.identificationModule.officialTitle
"Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Circadian Rhythm Sleep Disorders (protocolSection.conditionsModule.conditions)
  • Non-24 Hour Sleep-Wake Disorder (protocolSection.conditionsModule.conditions)
  • Autism Spectrum Disorder (protocolSection.conditionsModule.conditions)
  • Smith-Magenis Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.